Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.035 USD | +3.52% | +5.52% | -5.12% |
20/05 | Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants | MT |
06/05 | Foghorn Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.12% | 32Cr | |
+14.84% | 12TCr | |
+13.01% | 11TCr | |
-3.03% | 2.43TCr | |
+1.14% | 2.2TCr | |
-9.35% | 1.82TCr | |
-42.28% | 1.64TCr | |
-16.87% | 1.56TCr | |
+4.78% | 1.36TCr | |
+28.53% | 1.23TCr |
- Stock Market
- Equities
- FHTX Stock
- News Foghorn Therapeutics Inc.
- Foghorn Therapeutics Inc Appoints Michael LaCascia as Chief Legal Officer